Nephro Care India Ltd

NSE: NEPHROCARE · Healthcare · 3 announcements

Share price: ₹93.55
Market cap: ₹154.2 Cr
Revenue (annual): ₹88.73 Cr
Net profit (annual): ₹3.37 Cr
P/E (TTM): 45.8×Sector 57.8×
Promoter holding: 61.71%+0.00% QoQ
FII holding: 0.96%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements

8 Sep 2026 11:57 IST NSE

Adverse Business Impact

Nephro Care India Adverse Business Impact

Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.

Read the filing ↗

7 Aug 2026 17:20 IST NSE

Financial Results

Nephro Care India Q1 FY27 Results: Net Profit ₹1.6 Cr, Up 60.0% YoY

Nephro Care India Ltd reported revenue from operations of ₹29.2 Cr (+9.4% YoY) and net profit of ₹1.6 Cr (+60.0% YoY) for Q1 FY27.

Key figure: Net profit ₹1.6 Cr · +60.0% YoY

Open full results → Read the filing ↗

27 May 2026 19:05 IST NSE

Financial Results

Nephro Care India Q4 FY26 Results: Net Profit ₹1 Cr

Nephro Care India Ltd reported revenue from operations of ₹26.7 Cr and net profit of ₹1 Cr for Q4 FY26.

Key figure: Net profit ₹1 Cr

Open full results → Read the filing ↗